Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.

Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO.

PLoS One. 2011;6(10):e25333. doi: 10.1371/journal.pone.0025333. Epub 2011 Oct 21.

2.

Influenza-associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community-associated methicillin-resistant Staphylococcus aureus in Queensland, Australia.

Hayashi Y, Vaska VL, Baba H, Nimmo GR, Davis L, Paterson DL.

Intern Med J. 2012 Jul;42(7):755-60. doi: 10.1111/j.1445-5994.2011.02602.x.

PMID:
21981384
3.

Review: Defensins and cathelicidins in lung immunity.

Tecle T, Tripathi S, Hartshorn KL.

Innate Immun. 2010 Jun;16(3):151-9. doi: 10.1177/1753425910365734. Epub 2010 Apr 23. Review.

PMID:
20418263
4.

Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro.

Liang QL, Zhou K, He HX.

Biotechnol Lett. 2010 Mar;32(3):387-92. doi: 10.1007/s10529-009-0167-2. Epub 2009 Nov 26.

PMID:
19941035
5.

Human defensins and LL-37 in mucosal immunity.

Doss M, White MR, Tecle T, Hartshorn KL.

J Leukoc Biol. 2010 Jan;87(1):79-92. doi: 10.1189/jlb.0609382. Epub 2009 Oct 6. Review.

PMID:
19808939
6.

Innate immunity to influenza virus: implications for future therapy.

White MR, Doss M, Boland P, Tecle T, Hartshorn KL.

Expert Rev Clin Immunol. 2008 Jul 1;4(4):497-514.

7.

Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease.

Wohlford-Lenane CL, Meyerholz DK, Perlman S, Zhou H, Tran D, Selsted ME, McCray PB Jr.

J Virol. 2009 Nov;83(21):11385-90. doi: 10.1128/JVI.01363-09. Epub 2009 Aug 26.

8.

Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.

Doss M, White MR, Tecle T, Gantz D, Crouch EC, Jung G, Ruchala P, Waring AJ, Lehrer RI, Hartshorn KL.

J Immunol. 2009 Jun 15;182(12):7878-87. doi: 10.4049/jimmunol.0804049.

9.

Reawakening retrocyclins: ancestral human defensins active against HIV-1.

Venkataraman N, Cole AL, Ruchala P, Waring AJ, Lehrer RI, Stuchlik O, Pohl J, Cole AM.

PLoS Biol. 2009 Apr 28;7(4):e95. doi: 10.1371/journal.pbio.1000095.

10.

Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus.

White M, Kingma P, Tecle T, Kacak N, Linders B, Heuser J, Crouch E, Hartshorn K.

J Immunol. 2008 Dec 1;181(11):7936-43.

11.

Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season.

Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, Finelli L, Beekmann SE, Polgreen PM, Gorwitz R, Hageman J.

Ann Emerg Med. 2009 Mar;53(3):358-65. doi: 10.1016/j.annemergmed.2008.04.027. Epub 2008 Jun 4.

PMID:
18534715
12.

Beta-hairpin peptidomimetics: design, structures and biological activities.

Robinson JA.

Acc Chem Res. 2008 Oct;41(10):1278-88. doi: 10.1021/ar700259k. Epub 2008 Apr 16.

PMID:
18412373
13.
14.

Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid.

White MR, Tecle T, Crouch EC, Hartshorn KL.

Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1293-9. Epub 2007 Aug 24.

15.

alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s).

Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, Klotman ME.

J Infect Dis. 2007 Sep 15;196(6):835-43. Epub 2007 Aug 10.

PMID:
17703413
16.

Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin.

Daly NL, Chen YK, Rosengren KJ, Marx UC, Phillips ML, Waring AJ, Wang W, Lehrer RI, Craik DJ.

Biochemistry. 2007 Sep 4;46(35):9920-8. Epub 2007 Aug 8.

PMID:
17685559
17.

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.

Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, Tumpey TM, Katz JM.

J Virol. 2007 Mar;81(6):2736-44. Epub 2006 Dec 20.

18.

Lessons learned from reconstructing the 1918 influenza pandemic.

Garcia-Sastre A, Whitley RJ.

J Infect Dis. 2006 Nov 1;194 Suppl 2:S127-32.

PMID:
17163385
19.
20.

Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins.

Leikina E, Delanoe-Ayari H, Melikov K, Cho MS, Chen A, Waring AJ, Wang W, Xie Y, Loo JA, Lehrer RI, Chernomordik LV.

Nat Immunol. 2005 Oct;6(10):995-1001. Epub 2005 Sep 11.

Supplemental Content

Support Center